BMY vs JCI · P/E 17, rev $24.46B vs P/E 44, rev $23.60B
Bristol-Myers Squibb Company (BMY) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the BMY and JCI stock pages for the full models.
Not investment advice.